| Literature DB >> 33432395 |
Alexandros Giourgas1, Martin Durisin2, Anke Lesinski-Schiedat2, Angelika Illg2, Thomas Lenarz2.
Abstract
PURPOSE: The retrospective case review investigated the effect of cochlear implantation in subjects aged 61 years or older with respect to their auditory performance. The study also analysed the effect of age on the performance, and it drew a comparison between the outcomes of older and younger adults.Entities:
Keywords: Ageing; Cochlear implantation; Elderly; Speech perception
Mesh:
Year: 2021 PMID: 33432395 PMCID: PMC8486703 DOI: 10.1007/s00405-020-06566-8
Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN: 0937-4477 Impact factor: 2.503
Demographic information summarizing the study population
| Group 1 [ | Group 2 [ | |
|---|---|---|
| Gender | ||
| Female | 226 (50.7%) | 65 (59.1%) |
| Male | 220 (49.3%) | 45 (40.9%) |
| Age at implantation [years] | ||
| Mean (SD)/median (range) | 72.9 (6.3)/72.8 (61.1–89.5) | 32.0 (7.5)/33.4 (17.2–42.4) |
Duration of hearing loss [years] Mean (SD)/Median (range) | 27.2 (19.9)/23.0 (0.0–82.0) | 22.0 (11.6)/21.5 (0.0–42.0) |
| Implantation period | 14.01.2004 to 14.10.2016 | 11.09.2003 to 01.04.2016 |
| Type of implant | ||
Advanced bionics MedEl Nucleus | 141 (31.6%) 87 (19.5%) 218 (48.9%) | 31 (28.2%) 13 (11.8%) 66 (60.0%) |
Side of implantation Right/left | 237 (53.1%)/209 (46.9%) | 55 (50.0%)/50 (50.0%) |
Aetiology Genetical Iatrogenic Infection Neural Specific inner ear disease Trauma exposure Unknown | 12 (2.7) 4 (0.9) 37 (7.3) 4 (0.9) 42 (9.4) 19 (4.3) 328 (73.5) | 5 (4.5) 0 (0.0) 24 (21.8) 1 (0.9) 9 (8.2) 2 (1.8) 64 (58.2) |
| Comorbidities | ||
One Multiple Cognitive/neurological None Unknown | 125 (28.0) 23 (5.2) 21 (4.7) 274 (61.4) 3 (0.7) | 20 (18.2) 2 (1.8) 3 (2.7) 85 (77.3) 0 (0.0) |
Pre- and post-operative Freiburger Monosyllables Test (FMT) scores [% correct] for Group 1 and Group 2
| FMT score pre-implantation | FMT 12 months post-activation | |||
|---|---|---|---|---|
| Group 1 | Group 2 | Group 1 | Group 2 | |
Mean (SD) Median (range) | 441 6.6 (12.3) 0.0 (0–55.0) | 103 5.0 (10.6) 0.0 (0–45.0) | 395 52.2 (25.7) 55.0 (0–100) | 105 61.1 (27.7) 70.0 (0–95.0) |
Fig. 1Correlation between the scores in the Freiburger Monosyllables Test (FMT) and the age at testing for Group 1
Fig. 2Correlation between the scores in the Hochmair-Desoyer/Schulz/Moser-Sentence test in noise (HSMn) and the age at testing for Group 1
Scores [% correct] in the Freiburger Monosyllables Test (FMT) and the Hochmair-Desoyer/Schulz/Moser-Sentence test in noise (HSMn) for the subgroups 1a, 1b, 1c, and for Group 2
| Mean age at testing (range) | FMT 12 months post-activation mean (SD)/median (range) [ | HSMn 12 months post-activation mean (SD)/median (range) [ | |
|---|---|---|---|
| Group 1 | 73.6 (61.0–90.7) | 52.2 (25.7)/55.5 (0–100) [395] | 22.7 (24.8)/15.0 (0–90) [386] |
| Group 1a | 66.2 (61.0–69.8) | 57.2 (24.6)/65.0 (0–95) [107] | 28.7 (26.9)/23.5 (0–90) [104] |
| Group 1b | 74.3 (70.0–79.8) | 51.9 (26.0)/55.0 (0–100) [221] | 22.2 (24.6)/14.0 (0–88) [217] |
| Group 1c | 83.1 (80.0–90.7) | 45.3 (24.9)/45.0 (0–90) [67] | 14.5 (18.9)/9.0 (0–86) [65] |
| Group 2 | 33.0 (18.3–43.5) | 61.0 (27.7)/70.0 (0–95) [105] | 26.8 (27.9)/17.0 (0–91) [102] |
Fig. 3Scores [% correct] in the Freiburger Monosyllables Test (FMT) for Group 1 and 2 depending on the time at evaluation (i.e. first fitting [Group 1 n = 445; Group 2 n = 110]; 3 months [Group 1 n = 415; Group 2 n = 103]; 6 months [Group 1 n = 406; Group 2 n = 93]; 12 months [Group 1 n = 395; Group 2 n = 105] post-implantation)
Fig. 4Scores [% correct] in the Hochmair-Desoyer/Schulz/Moser-Sentence test in noise (HSMn) for Group 1 and 2 depending on the time at evaluation (i.e. first fitting [Group 1 n = 440; Group 2 n = 110]; 3 months [Group 1 n = 409; Group 2 n = 101]; 6 months [Group 1 n = 400; Group 2 n = 91]; 12 months [Group 1 n = 386; Group 2 n = 102] post-implantation)
Scores [% correct] in the Freiburger Monosyllables Test (FMT) and Hochmair-Desoyer/Schulz/Moser-Sentence test in noise (HSMn) for Group 1 depending on comorbidities
| FMT preoperatively | FMT 12 months post-activation | HSMn 12 months post | |
|---|---|---|---|
| Category | Mean (SD)/median (range) [ | Mean (SD)/median (range) [ | Mean (SD)/median (range) [ |
One comorbidity Multiple comorbidities Cognitive/neurological None | 6.1 (12.3)/0.0 (0–55) [123] 4.3 (11.4)/0.0 (0–40) [22] 2.3 (4.7)/0.0 (0–15) [20] 7.9 (13.6)/0.00 (0–60) [273] | 48.1 (25.7)/52.5 (0–95) [110] 51.7 (29.9)/60.0 (0–85) [21] 46.3 (26.9)/50 (0–90) [14] 54.7 (24.9)/60.0 (0–100) [248] | 23.0 (25.9)/16.5 (0–88) [106] 20.1 (23.2)/12.5 (0–79) [20] 15.0 (17.5)/3.0 (0–46) [14] 23.3 (24.8)/15.0 (0–90) [244] |